Cell Isolation Market Size, Share Key Players, Segment Analysis and Future Scope

The primary factors propelling the cell isolation market to prosperity are the increasing demand for biopharmaceuticals, funding by the government for cell-based research, and rising number of studies on personalized medicine. The market, which generated a revenue of $4.6 billion in 2017, is predicted to progress at an 18.8% CAGR during 2018-2023 (forecast period), to ultimately value $12.6 billion by 2023. For diagnostic testing and disease prognosis, cells of various types are identified and extracted from the body.

Download sample copy of this report@ http://bit.ly/2LXOfGk

Cancer research, biomolecule isolation, tissue regeneration, stem cell research, therapeutics, and in-vitro diagnostics are the various categories, when the cell isolation market is segmented on the basis of application. During the historical period (2013-2017), the biomolecule isolation category held the largest share, and it is also expected to grow the fastest during the forecast period. This would be on account of the increasing preference of pharmaceutical organizations on using biomolecules for drug development, as they have fewer side-effects than small molecules.

The increasing demand for biopharmaceuticals, including biosimilars, monoclonal antibodies (mAb), and recombinant proteins, is itself one of the most significant growth drivers for the market. They are being rapidly used to treat common chronic diseases as well as disorders which were earlier untreatable. Since their production is comparatively cost-effective than pharmaceuticals procured from synthetic sources, they are witnessing a surging demand. The most common condition treated with biopharmaceuticals is cancer, which was expected to be found in 1,735,350 people in the U.S., in 2018, as per the National Cancer Institute.

Pre-Purchase Inquiry at@ https://bit.ly/2RplcAX

In 2017, North America was the largest cell isolation market across the world, with an around 38.0% revenue share. This was because a large number of biotechnology and pharmaceutical organizations, academic institutions, and research laboratories, which use the technique, are present in the region. During the forecast period, Asia-Pacific (APAC) is expected to observe the fastest growth, at a 22.1% CAGR, due to the rising focus on applied and basic medical research here, especially in India and China, where a number of institutes dedicated to cell-based research have been founded.

Thus, with the surging requirement for biopharmaceuticals, especially those needed to treat cancer, the usage of cell isolation would continue to increase around the globe.

Contact:
P&S Intelligence
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: http://psintelligence.blogspot.com/

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

This release was published on openPR.